Concepedia

Mario López Contreras

ML

Statistics

Publications

4

Citations

367

H-Index

4

Active since

2002

Affiliations

Mexican Social Security Institute(Current)

Universidad Nacional Autónoma de México

Hospital General De Zona

Mario López Contreras is an author at Mexican Social Security Institute specializing in medicine, oncology, and cervical intraepithelial neoplasia.

Publications per year

2002–2007

4

Publications

4

Regression of papilloma high-grade lesions (CIN 2 and CIN 3) is stimulated by therapeutic vaccination with MVA E2 recombinant vaccine

E García-Hernández, J. L. González‐Sánchez, A Andrade-Manzano et al. · Cancer Gene Therapy · 2006 · 149 citations

Medicine, Immunology, Oncology +17

Therapeutic Vaccination with MVA E2 Can Eliminate Precancerous Lesions (CIN 1, CIN 2, and CIN 3) Associated with Infection by Oncogenic Human Papillomavirus

Carlos Manuel Corona Gutierrez, Alberto Tinoco, Tania Navarro et al. · Human Gene Therapy · 2004 · 135 citations

Medicine, Gynecology, Oncology +17

MVA E2 Recombinant Vaccine in the Treatment of Human Papillomavirus Infection in Men Presenting Intraurethral Flat Condyloma

Antonio Albarran y Carvajal, Alfonso de la Garza, Benitez Jose Cecilio Cruz Quiroz et al. · BioDrugs · 2007 · 62 citations

Medicine, Oncology, Urology +15

A Phase II Study: Efficacy of the Gene Therapy of the MVA E2 Recombinant Virus in the Treatment of Precancerous Lesions (NIC I and NIC II) Associated with Infection of Oncogenic Human Papillomavirus

Carlos Manual Corona Gutierrez, Alberto Tinoco, Mario López Contreras et al. · Human Gene Therapy · 2002 · 21 citations

Medicine, Infectious Diseases, Oncology +17

1–4 of 4